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ABSTRACT 
Objective : The aim was to test the role of oxygen- derived 
free radicals in the development of myocarditis. We investigated 
the effects of polyethylene glycol-conjugated superoxide 
dismutase (PEG- SOD, an enzyme catalyzing the conversion of o2
- to 
H2o2) and polyethylene glycol-conjugated catalase (PEG- catalase, 
accelerating upon 
coxsackievirus B3 (CB3) myocarditis. 
Methods Two-week- old male c3H/He mice were inoculated 
intraperitoneally with 103 plaque- forming units of CB3. PEG-SOD, 
1x103U/kg/day and PEG- SOD, 1x103U/kg/day plus PEG- catalase, 
1x103U/kg/day were administered subcutaneously daily on days 0 to 
14. Treated groups were compared to the infected control. 
Results : On day 7, there were no significant differences in 
pathologic scores among all groups. On day 14, however, the 
scores of cellular infiltration, myocardial necrosis and 
calcification were significantly lower in PEG- SOD, 1x103U/kg/day 
treated group and PEG-SOD, 1x103U/kg/day plus PEG- catalase, 
1x103U/kg/day treated group compared to the control. Futhermore, 
there were no signifficant differences in pathologic scores 
between only PEG-SOD treated group and a combination treatment 
with PEG-SOD plus PEG- catalase. There were no significant 
differences in the myocardial virus titers on day 7 among the 
three groups. On day 14, virus was not detected from the 
myocardium in the three groups. 
Conclusions The results suggest that superoxide anion is 
mostly responsible for myocyte injury in CB3 myocarditis in mice, 
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and that hydrogen peroxide formed as a consequence of dismutation 
of superoxide anion may not play a significant role in the 
development of myocarditis. Superoxide anion is one of the most 
important members in free radical- mediated injury in CB3 
myocarditis in mice and the administration of PEG-SOD alone has 
therapeutic potential for clinical CB3 myocarditis equal to the 
combination of the two agents. 
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INTRODUCTION 
Infiltration of the myocardium with inflammatory cells 
occurs during infection with a variety of viruses. 1·2) Usually, 
the infiltrate comprises mononuclear cells that are focal or 
diffusely scattered throughout the myocardium. Myofiber necrosis 
is an important feature of this lesion. Coxsackievirus B3 (CB3) 
is an enterovirus which can cause acute myocarditis in man. 1·2) 
In addition, viral myocarditis is considered a cause of dilated 
cardiomyopathy.l-3) 
There is no general agreement concerning effective therapy 
for viral myocarditis. Trials with steroids, 4·5) nonsteroidal 
antiinflammatory drugs, 6) irnmunosuppressi ve therapy, 7-9) S -
blockers, 10) angiotensin converting enzyme inhibitors, 11) and 
other therapeutic modalities12) have been attempted. 
Superoxide dismutase (SOD), a potent scavenger of oxygen 
free radicals and catalase, accelerating the reaction of hydrogen 
peroxide to water and oxygen have been used for the treatment of 
several diseases, such as ischemic myocardial injury, 13-lB) acute 
pancreatitis, 19-22) Behcet's disease,23) influenza virus 
infection. 24·25) A recent study by Rezkalla et al. ll) suggested 
that the cardioprotective effects of angiotensin converting 
enzyme inhibitors against CB3 myocarditis may be due in part to 
their apparent ability to act as nonspecific antioxidants or 
specific scavengers of cytotoxic oxygen·-derived free radicals, 
and that, therefore, oxygen free radicals may be involved in the 
pathogenesis of CB3 myocarditis. Polyethylene glycol-conjugated 
superoxide dismutase (PEG-SOD) and polyethylene glycol-conjugated 
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catalase (PEG-catalase)26�27) are known to have a plasma half­
life in excess of 30 hours. 
In a previous study, 28) we have shown that the 
administration of PEG-SOD, lxl03U/kg/day reduced the severity of 
CB3 myocarditis. The present study was designed to determine 
1) whether hydrogen peroxide formed as a consequence of 
dismutation of superoxide anion may play a role in 
myocyte injury and whether removal of hydrogen peroxide 
(H2o2) with catalase is necessary to attenuate cell 
damage in CB3 myocarditis in mice, 
2) whether SOD alone may provide a level of protection that 
is equal to the combination of SOD and catalase. 
To answer these questions, we examined the effects of PEG-SOD and 
PEG-catalase upon murine CB3 myocarditis. 
METHODS 
Infection protocol 
The virus stock of coxsackievirus B3 (CB3) (Nancy strain 
American Type Culture Collection) was prepared in culture of 
k idney cells of African green monkey in Eagle's minimum essential 
medium. Virus suspensions were centrifuged after the cytopathic 
effect had developed, and viral stock had a titer of more than 
109 plaque�forming units/ml, determined by tissue culture. 
Two-week-old, male, inbred, certified virus-free C3H/He mice 
(Shizuoka Laboratory Animal Center, Shizuoka) were used. The 
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animals were inoculated intraperitoneally with 0. 1 ml of virus 
suspension containing 103 plaque-forming units of CB3. They were 
supplied with mother mice throughout the entire period. 
All animals were cared for in accordance with the 
institutional policies and guidelines of Toyama Medical and 
Pharmaceutical University. 
Treatment protocol (Figure 1) 
PEG-SOD (Sigma Chemical Co. , St. Louis) and PEG-catalase 
(Sigma Chemical Co. , St. Louis) were administered subcutaneously 
daily at rotated sites, the actual dose for each experiment being 
calculated from mouse weight at the beginnig and middle of the 
experiment. The dosage of PEG- SOD was 1x103U/kg/day, and that of 
PEG-catalase 1xl03U/kg/day. These doses were chosen based on 
previous reports. 14, 16, 17, 20, 26, 27) 
Ninety mice were randomly selected to no treatment (n=30), 
to treatment with PEG-SOD, 1x103U/kg/day (n=30), and to treatment 
with PEG- SOD, 1x103U/kg/day plus PEG-catalase, 1x103U/kg/day 
(n=30). Mice in the untreated group were injected subcutaneously 
with 0. 1 ml of saline during the treatment period. Starting 
simultaneously after the virus inoculation, treatment was 
administered for 14 days. The mice were observed daily, and 
necropsy was performed immediately on those mice found dead. 
Ten mice in each group were weighed and k illed on day 7 by 
bleeding from the retroorbital plexus. Heart, liver and lungs 
were isolated and weighed aseptically. They were processed for 
virologic and pathologic studies. Mice surviving to the end of 
treatment period were also weighed, sacrificed and necropsied. 
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Heart, liver and lung were isolated and weighed. The organs were 
processed for virologic and pathologic studies. 
To avoid the postmortem changes and to match the time 
course, pathologic study was performed only upon the mice 
sacrificed on days 7 and 14. 
Additional control groups of uninfected mice, treated for 14 
days with saline (n=5), 1x103U/kg/day of PEG-SOD (n=5), 
1x103U/kg/day of PEG- SOD plus 1x103U/kg/day of PEG-catalase (n=5) 
were also examined. 
Pathologic study 
Tissues (heart, pancreas, thymus, spleen, lungs, liver, 
kidney and psoas muscle) were processed by standard methods, 
embedded in paraffin, cut into 5�m thi.ck sections, and stained 
with hematoxylin- eosin. Myocardial sections were graded by two 
of the authors (Y . H. and C. K. ), bli.nded to the respective 
treatment groups, for the severity of cellular infiltraion, 
necrosis and calcification of the ventri.cles. The mean value was 
cited. 
The pathologic criteria for grading of the severity of 
infiltration, necrosis or calcification were : 
Grade 1 (mild) 
Grade 2 (slight) 
Grade 3 (moderate) 
Grade 4 (severe) 
Grade 5 (very severe) 
one or two small foci 
several small foci 
multiple small foci 
or several large foci 
multiple large foci 
diffuse infiltration 
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necrosis or calcification 
The other organs were evaluated for evidence of viral or 
other pathologic lesions. 
Virological study 
For infectivity assays, hearts were removed aseptically, 
weighed, and homogenized in 2 ml of phosphate buffered saline. 
After centrifugation at 1, 500 rpm for 15 min, virus titers in the 
supernatants were determined by the plaque assay method. 
In brief, African green monkey kidney cells were suspended 
at a concentration of 1x106/ml in Eagle's minimum essential 
medium with ·5% fetal calf serum plus 100 mg/ml of penicillin and 
streptomycin in six well plates and allowed to grow for 2 or 3 
days at 37°C in 5% co2. After adsorption, the cells were 
overlaid with 3 ml of Eagle's minimum essential medium containing 
5% fetal serum and 1% methyl cellulose. After 2 days of 
incubation at 37°C in a humidified atmosphere containing 5% co2, 
the cells were fixed with acetic acid and methanol (at a ratio of 
1:3) and stained with 1% crystal violet; plaques were then 
counted with an inverted microscope. 
Statistics 
Heart- to-body, lung-to-body and liver- to-body weight ratios 
were analyzed by one way analysis of variance with multiple 
sample comparisons, comparing treated group versus control group 
on days 7 and 14. One way analysis of variance with multiple 
sample comparisons was used to evaluate difference in the 
pathologic scroes. Kaplan-Meier's method was used to determine 
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the significance of differences in survival rates. A probability 
value of less than 0. 05 was considered statistically significant. 
RESULTS 
Infection with CB3 produced a similar and pathologic picture 
to that reported previously. 8'9, 12, 29) In brief, three days 
after the virus inoculation, the mice appeared ill; some 
developed coat ruffling, weakness and irritability. Grossly, the 
myocardium had pale yellow patches that correlated with the 
inflammation, necrosis and calcification seen microscopically. 
Mortality (Figure 2) 
Two mice in the control group, 10 in PEG-SOD, 1x103U/kg/day 
treated group, 6 in PEG-SOD, 1x103U/kg/day plus PEG-catalase, 
lx103U/kg/day treated group had died by day 14; the survival rate 
on day 14 was 90. 0% (18/20) in control group, 50. 0% (10/20) in 
PEG-SOD, 1x103U/kg/day treated group, 70. 0% (14/20) in PEG-SOD, 
lx103U/kg/day plus PEG-catalase, 1x103U/kg/day treated group. 
The difference between control group and PEG-SOD, 1x103U/kg/day 
treated group was significant. 
There was no death of uninfected mice in three groups 
throughout the entire period. And PEG-SOD and PEG-SOD plus PEG­
catalase did not affect body weight gains in uninfected mice. 
Cardiac pathology (Figures 3, 4 and 5) 
On day 7, there were no significant differences in the score 
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of cardiac pathology (infiltration, necrosis and calcification) 
among the three groups. 
On day 14, the scores of cellular infiltration, myocardial 
necrosis and calcification were significantly lower in PEG-SOD, 
1x103U/kg/day treated group and in PEG-SOD, 1x103U/kg/day plus 
PEG-catalase, 1x103U/kg/day treated group compared to the 
control. 
No abnormalities were found in the heart of uninfected mice 
in the three groups. 
Pathology of other organs 
Pancreatitis, probably virus-induced, was noted in mice in 
each infected group. No viral lesions were noted in the thymus, 
lung, liver, kidney, spleen or muscle. There were no significant 
changes in the incidence of congestion of lung and liver in three 
infected groups. 
No abnormal findings were observed in the pancreas, thymus, 
lung, liver, kidney, spleen or muscle in three uninfected groups. 
Heart, Lung and Liver weights (Table 1) 
On day 7, there were no significant differences in heart, 
lung and liver weights to body weight ratios. 
were also obtained on day 14. 
Myocardial virus titers (Table 2) 
Similar results 
There were no significant differences in the myocardial 
virus titers on day 7 among the three groups. On day 14, the 
virus was not detected from the myocardium in the three groups. 
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DISCUSSION 
The results of present study clearly demonstrated that the 
severity of myocardial lesions of CB3 myocarditis in PEG-SOD, 
1xl03U/kg/day and PEG-SOD, 1x103U/kg/day plus PEG-catalase, 
1xl03U/kg/day treated groups were significantly lower compared to 
the control. 
significantly 
Myocardial virus titers did not differ 
in all groups. Furthermore, there were no 
significant differences in heart, lung and liver weights to body 
weight ratios among all groups. This finding may be of great 
value for understanding the pathogenesis of CB3 myocarditis. 
There has been a substantial number of experimental studies 
testing the efficacy of superoxide disrnutase (SOD) and catalase 
on several diseases. 13· 17·24·25) Especially, many investigators 
in the fields of inflammation have expressed a growing awareness 
to oxygen-derived free radicals as a cause of tissue injury; 
particular attention has been focused upon the pivotal 
deleterious effect of free radicals in the pathogenesis of 
influenza virus infection, 24·25) pancreatitis, 19- 22) and other 
inflammatory diseases. 23) Westlin and Mullane30) suggested that 
the cardioprotective effects of angiotensin converting enzyme 
inhibitors that contain a sulfhydryl group (such as captopril and 
zofenopril) may be due in part to their apparent ability to act 
as nonspecific antioxidants or specific scavengers of 
oxygen-derived free radicals. Also, Rezkalla et 
cytotoxic 
al.ll) 
suggested that the postulated oxygen free radical scavenging 
properties of captopril might be beneficial in acute CB3 murine 
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myocarditis. 
Huber and Saifer31) reported that unmodified SOD was removed 
from the serum with a half-time of about 6 min in mice. 
Unfortunately, this short plasma life limits the clinical 
usefulness of SOD as free radical scavengers. The attachment of 
polyethylene glycol (PEG) to SOD and catalase results in an 
extension of the plasma half life and in the suppression of 
immunogenicity of the conjugates. Viau27) reported that PEG-SOD 
administered intramuscularly remained at peak concentrations for 
24 hours and stayed in the circulation for 8 days. Similarly, 
they reported that the blood-circulating life of catalase was 
increased from a few minutes to 3 days through the attachment of 
PEG to the enzyme. 
Neutrophils and macrophages are known to produce superoxide 
free radicals (02
-) and hydrogen peroxide (H2o2) .
32·33) which 
normally are involved in the killing of ingested or invading 
microbes. However, the activated oxygen can also cause tissue 
injury under conditions such as ischemic reperfusion and 
inflammatory diseases. Because the inflamed myocardium of viral 
myocarditis is 
infiltrate, 1·2•29) 
associated 
there may 
with 
be a 
an intense 
possibility that 
leukocyte 
oxygen 
radicals generated from these mononuclear cells could contribute 
to additional myocyte damage. 
In the previous study, 28) we have shown that the 
administration of PEG-SOD, lxl03U/kg/day reduced the severity of 
myocardial lesion of CB3 myocarditis. The study, however, did 
not attempt to discern the relative roles of the various oxygen 
species in CB3 myocarditis in mice. Both o2 
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theoretically capable of producing myocellular damage in 
themselves. In addition, Oz
- and HzOz can react to generate the 
hydroxyl radical ('OH), an oxidant considerably more potent than 
either of its precursors. Consequently,, accumulation of Oz
- or 
HzOz could produce myocardial dysfunction either directory, via 
the cytotoxic action of these species, or indirectory, via ·oH 
generation. Administration of PEG- SOD plus PEG-catalase may help 
to discern these two mechanisms because this combinaton would not 
interfere with injury caused directoly by Oz or HzOz but it 
should attenuate the toxic action of ·oH. Such information would 
not only help to elucidate the mechanisms of radical-mediated 
damage but may also have therapeutic implications. Both SOD and 
catalase are highly specific enzymes; SOD acts only by catalyzing 
the dismutation of Oz to H20z and Oz. while catalase accelerates 
the conversion of HzOz to HzO and Oz. 
It is generally accepted that a biphasic disease process 
results when mice are infected with CB3. l, z, zg) During the acute 
phase, viral replication in the myocardium results in myocardial 
necrosis with inflammation during the first week. 
virus has been eliminated from the myocardium, a 
After the 
chronic 
inflammation results in progressive myocyte damage. There is a 
suggestion that the chronic phase results from cell-mediated 
immune response to a neoantigen that developed during the acute 
phase of illness. l, Z, s, g, zg) In addition to the documented 
immunopathqlogic mechanisms, 8·9·Z9) it was suggested, in this 
study, that cardiac lesions of CB3 myocarditis in PEG- SOD, 
lxl03U/kg/day and PEG-SOD, lxl03U/kg/day plus PEG-catalase, 
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lxl03U/kg/day treated groups were les� severe than those of 
untreated group; treatment with PEG-SOD or PEG-SOD plus PEG­
catalase did not affect clearance of the virus from the 
myocardium. 
infiltrating 
Accordingly, oxygen free radicals generated from 
leukocytes and macrophages in the inflamed 
myocardium may contribute to the further development of CB3 
myocarditis. 
Two possible mechanisms of which treatment of PEG-SOD 
aggravated mortality might have been considered. One is the 
toxicity of PEG-SOD itself. The other is aggravation of virus­
induced at extracatiac sites, such as pancreatitis. 
The limitations of the present study are as follows. 
Although we had already examined the serial changes in lymphocyte 
subsets in the heart of c3H!He mice inoculated with CB3,
29) it 
might be necessary to demonstrate macrophages and neutrophils 
in the inflamed myocardium. However. even in conventional 
hematoxylin-eosin stainings, these mononuclear cells were 
well distinguished. Furthermore, in this study, we might have 
discussed the possibility of treatment over shorter period. Also 
it might be necessary to initiate treatment at the onset of 
myocardial inflammation rather than at the time of infection. 
In conclusion, superoxide anion is one of the most important 
members in free radical-mediated injury in CB3 myocarditis in 
mice, and that the administration of PEG-SOD alone has 
therapeutic potential for clinical CB3 myocarditis equal to the 
combination of PEG-SOD plus PEG-catalase. 
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FIGURE LEGENDS 
Figure 1 Schematic diagram of experimental design 
PEG-SOD (polyethylene glycol-conjugated superoxide 
dismutase) and PEG-catalase (polyethylene glycol-
conjugated catalase) were administered subcutaneously 
daily on days 
1x103U/kg/day, 
1xl03U/kg/day. 
0 to 14. The dosage of PEG-SOD was 
and that of PEG- catalase was 
Figure 2 Plots of survival 
Two mice in the control group, 10 in PEG-SOD, 
lxl03U/kg/day treated group, 6 in PEG-SOD, 
1x103U/kg/day plus PEG- catalase, 1x103U/kg/day treated 
group had died by day 14. The difference between 
control group and PEG-SOD, lx103U/kg/day plus PEG­
catalase, 1x103U/kg/day treated group was significant. 
Figure 3 Results of cardiac pathology on day 7 
There were no significant differences in the score of 
cardiac pathology among the three groups. 
Figure 4 Results of cardiac pathology on day 14 
The scores of cellular infiltration, myocardial 
necrosis and calcification were significantly lower in 
�EG-SOD, lx103U/kg/day treated group and PEG- SOD, 
1xl03U/kg/day plus PEG-catalase, lxl03U/kg/day treated 
group compared to the control. 
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Figure 5 Sections of myocardium 
Fourteen days after virus inoculation, marked 
inflammatory cell infiltration and extensive myocardial 
necrosis were seen in a mouse of the control group (A). 
On the other hand, infiltration and necrosis were less 
severe in the heart of a mouse in PEG-SOD, 
lxl03U/kg/day treated group (B) and in the heart of a 
mouse in PEG-SOD, lxl03U/kg/day plus PEG-catalase, 
lxl03U/kg/day treated group (C). 
Hematoxylin-eosin, x380. 
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